$255 Million is the total value of Eagle Health Investments LP's 25 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 29.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IQV | Buy | IQVIA HLDGS INC | $19,348,000 | +49.2% | 100,177 | +38.4% | 7.59% | -8.5% |
VRTX | Buy | VERTEX PHARMACEUTICALS INC | $19,006,000 | +54.6% | 88,444 | +70.1% | 7.46% | -5.1% |
HUM | Buy | HUMANA INC | $18,833,000 | +47.3% | 44,921 | +44.2% | 7.39% | -9.6% |
AGIO | Buy | AGIOS PHARMACEUTICALS INC | $18,314,000 | +506.4% | 354,650 | +408.8% | 7.19% | +272.0% |
AZN | Buy | ASTRAZENECA PLCsponsored adr | $17,740,000 | +54.2% | 356,789 | +55.1% | 6.96% | -5.4% |
NTRA | Buy | NATERA INC | $17,099,000 | +118.6% | 168,394 | +114.2% | 6.71% | +34.2% |
UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $15,573,000 | +46.6% | 93,100 | +33.0% | 6.11% | -10.1% |
ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $15,274,000 | +37.0% | 108,179 | +26.1% | 6.00% | -16.0% |
BPMC | Buy | BLUEPRINT MEDICINES CORP | $12,947,000 | +86.0% | 133,163 | +114.6% | 5.08% | +14.2% |
ARGX | Buy | ARGENX SEsponsored adr | $11,740,000 | +103.8% | 42,632 | +117.7% | 4.61% | +25.1% |
AXNX | Buy | AXONICS MODULATION TECHNOLOG | $11,676,000 | +27.9% | 194,965 | +6.6% | 4.58% | -21.5% |
TMO | Sell | THERMO FISHER SCIENTIFIC INC | $9,562,000 | -17.4% | 20,951 | -15.7% | 3.75% | -49.3% |
UTHR | New | UNITED THERAPEUTICS CORP DELput | $8,364,000 | – | 50,000 | +100.0% | 3.28% | – |
ADPT | Buy | ADAPTIVE BIOTECHNOLOGIES COR | $8,141,000 | +64.8% | 202,220 | +142.1% | 3.20% | +1.1% |
INSP | New | INSPIRE MED SYS INC | $7,752,000 | – | 37,453 | +100.0% | 3.04% | – |
JWS | Buy | JAWS ACQUISITION CORP | $6,573,000 | +160.3% | 496,100 | +163.5% | 2.58% | +59.8% |
MRTX | New | MIRATI THERAPEUTICS INC | $6,235,000 | – | 36,400 | +100.0% | 2.45% | – |
OM | Buy | OUTSET MED INC | $5,292,000 | +29.3% | 97,300 | +35.1% | 2.08% | -20.6% |
DXCM | DEXCOM INC | $4,960,000 | -2.8% | 13,800 | 0.0% | 1.95% | -40.3% | |
GH | Sell | GUARDANT HEALTH INC | $4,314,000 | +3.1% | 28,260 | -12.9% | 1.69% | -36.7% |
SEER | Buy | SEER INC | $4,177,000 | +272.0% | 83,500 | +317.5% | 1.64% | +128.4% |
DFHT | Buy | DEERFIELD HEALTHCARE TECH AC | $4,122,000 | +879.1% | 340,075 | +1159.2% | 1.62% | +501.5% |
DRNA | Buy | DICERNA PHARMACEUTICALS INC | $4,120,000 | +171.1% | 161,125 | +133.5% | 1.62% | +66.4% |
FDMT | 4D MOLECULAR THERAPEUTICS IN | $2,169,000 | +4.6% | 50,000 | 0.0% | 0.85% | -35.8% | |
OLK | New | OLINK HLDG ABsponsored ads | $1,440,000 | – | 40,000 | +100.0% | 0.56% | – |
LGVW | Exit | LONGVIEW ACQUISITION CORP | $0 | – | -114,100 | -100.0% | -1.44% | – |
ILMN | Exit | ILLUMINA INC | $0 | – | -15,700 | -100.0% | -3.72% | – |
ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -42,929 | -100.0% | -4.29% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-04-23
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
IQVIA HLDGS INC | 12 | Q3 2023 | 9.6% |
UNITED THERAPEUTICS CORP DEL | 12 | Q3 2023 | 8.7% |
ALNYLAM PHARMACEUTICALS INC | 12 | Q3 2023 | 8.5% |
NATERA INC | 12 | Q3 2023 | 8.5% |
ARGENX SE | 12 | Q3 2023 | 7.0% |
DEXCOM INC | 12 | Q3 2023 | 5.7% |
OUTSET MED INC | 12 | Q3 2023 | 7.3% |
AGIOS PHARMACEUTICALS INC | 12 | Q3 2023 | 7.2% |
ADAPTIVE BIOTECHNOLOGIES COR | 12 | Q3 2023 | 5.1% |
GUARDANT HEALTH INC | 12 | Q3 2023 | 3.8% |
View Eagle Health Investments LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-12 |
13F-HR | 2023-10-27 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-11 |
13F-HR | 2022-05-12 |
13F-HR | 2022-02-10 |
13F-HR | 2021-10-20 |
View Eagle Health Investments LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.